Close Menu

Books in a Library

Porphyromonas gingivalis LPS-induced IL-1β and IL-8 Expression by Reducing MAPK Activation in THP-1 Cells

DOI: 
10.7727/wimj.2016.081

ABSTRACT

Objective:To investigate the inhibitory effects of alpha-mangostin on Porphyromonas gingivalis lipopolysaccharide (LPS)-induced production of pro-inflammatory cytokines and activation of mitogen-activated protein kinase (MAPK) signaling in THP-1 cells.

Methods: The cell viability after P. gingivalis LPS or alpha-mangostin treatment was measured with MTS assay. The ability of alpha-mangostin to modulate the THP-1 cell response to P. gingivalis LPS stimulation was assessed by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) method for interleukin (IL)-1β and IL-8 expression and by western blotting for the activation of MAPK signaling.

Results: Alpha-mangostin reduced the expression of IL-1β and IL-8 in P. gingivalis LPS-stimulated THP-1 cells. Alpha-mangostin also suppressed P. gingivalis LPS-induced phosphorylation of c-Jun N-terminal kinase (JNK), extracellular-signal-regulated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (p38 MAPK).

Conclusion: Alpha-mangostin suppresses the production of inflammatory cytokine in P. gingivalis LPS-stimulated THP-1 cells, possibly by reduction the activation of MAPK. These results suggest that alpha-mangostin may be used as an anti-inflammatory agent in adjunctive treatment of periodontal disease.

Accepted: 
31 Mar, 2016
PDF Attachment: 
e-Published: 05 Apr, 2016

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Top of Page